Alzheimer's vs Dementia: What's the Difference and Why It Matters for Care Planning

The question families type into search at 2 a.m. — is it Alzheimer's or dementia? — usually stems from a doctor who used one term and a pamphlet that used the other. The confusion isn't trivial. It changes the treatment your parent can access, the timeline you're planning around, and the type of care facility that will actually serve them well.

Here's the short answer: dementia is the umbrella term for a group of symptoms — memory loss, impaired reasoning, personality changes — severe enough to interfere with daily life. Alzheimer's disease is one specific cause of those symptoms, accounting for 60–80% of all cases. The remaining 20–40% includes vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed presentations.

Why the Specific Diagnosis Changes Everything

Treatment options vary by type. Alzheimer's has FDA-approved medications that can slow progression in early stages — cholinesterase inhibitors (donepezil, rivastigmine) and the newer anti-amyloid therapies. Lewy body dementia patients are dangerously sensitive to typical antipsychotic medications — a prescription that might help an Alzheimer's patient with agitation can cause a life-threatening reaction in an LBD patient. Vascular dementia has no dementia-specific drug treatment, but aggressively managing the underlying cardiovascular risk factors (blood pressure, cholesterol, diabetes) can slow or prevent further decline.

Progression patterns differ. Alzheimer's follows a relatively predictable downward slope mapped by the Global Deterioration Scale — 7 stages from normal aging to complete dependence, typically spanning 8–12 years. Vascular dementia progresses in a staircase pattern — sudden drops after strokes, followed by plateaus. Lewy body dementia fluctuates dramatically, with good hours and bad hours within the same day. Frontotemporal dementia often progresses faster than Alzheimer's, with prominent behavioral changes rather than memory loss.

Care facility requirements are different. Not all memory care units are equipped for every type. A facility experienced with Alzheimer's residents may not have protocols for managing LBD's antipsychotic sensitivity or FTD's behavioral disinhibition. Asking "what types of dementia do your residents have?" during facility tours is as important as asking about staffing ratios.

How to Get the Right Diagnosis

A general practitioner can screen for cognitive impairment using tools like the Mini-Mental State Exam (MMSE) or the Montreal Cognitive Assessment (MoCA). But these screens identify that there's a problem — not what's causing it. For a specific diagnosis, you need:

Comprehensive neuropsychological testing. A battery of tests measuring memory, language, executive function, visual-spatial ability, and attention. The pattern of deficits points toward the underlying cause. Memory-first decline suggests Alzheimer's. Executive function collapse with preserved memory suggests vascular or frontotemporal. Visual-spatial deficits with hallucinations suggest Lewy body.

Brain imaging. MRI can reveal patterns of atrophy (frontotemporal dementia shows pronounced frontal and temporal lobe shrinkage), evidence of strokes (vascular dementia), or hippocampal volume loss (Alzheimer's). A DaTscan can help differentiate Lewy body dementia from Alzheimer's by measuring dopamine transporter levels.

Blood work and labs. To rule out reversible causes — thyroid dysfunction, vitamin B12 deficiency, normal pressure hydrocephalus, medication side effects — that can mimic dementia symptoms.

In the US, the cognitive care plan visit (CPT 99483) covers comprehensive assessment under Medicare. In the UK, NHS memory clinics provide assessment at no cost but wait times can stretch to several months. In Australia, the ACAT assessment through My Aged Care is free and determines eligibility for support services.

The Planning Implications

Regardless of the specific type, certain actions are time-critical:

Power of Attorney must be signed while your parent has capacity. This applies to every dementia type, but the timeline varies. Alzheimer's patients in Stage 4 (mild dementia) typically retain capacity. LBD patients may fluctuate — capacity might be present in the morning and absent by afternoon. FTD patients may lose judgment and insight early, even before memory is affected, making the POA window shorter than families expect.

Financial planning depends on expected duration. An Alzheimer's diagnosis at 75 suggests planning for 8–12 years of care. Early onset at 58 could mean 15+ years. Vascular dementia's trajectory depends on whether further strokes can be prevented. These timelines determine how much money needs to be protected and when Medicaid or other benefit planning should begin.

The diagnosis affects benefit eligibility. In the US, hospice eligibility under Medicare Part A uses the FAST scale to determine prognosis — a tool designed primarily for Alzheimer's. For non-Alzheimer's dementias, physicians use different clinical criteria, and families sometimes face pushback from hospice agencies unfamiliar with LBD or FTD progression patterns.

What to Do This Week

If your parent has a generic "dementia" diagnosis without a specific type, request a referral to a memory clinic or behavioral neurologist for comprehensive assessment. The specific diagnosis won't change the fact that your parent has dementia — but it will change the medications that are safe, the timeline you're planning around, and the type of care facility that can actually help.

The Understanding Dementia Stages: A Family Roadmap covers Alzheimer's, vascular, Lewy body, and frontotemporal dementia side by side — mapping each type's staging to the legal, financial, and care decisions families need to make at each phase.